Double-blind, Randomised, Placebo-controlled Trial Investigating BIRT 2584 XX in Patients With Moderate/Severe Psoriasis
type: MedicalStudy
description: A 12 Week Double-blind, Randomised, Placebo-controlled, Modified Dose-escalation Trial to Investigate Safety, Efficacy, and Pharmacokinetics of BIRT 2584XX Tablets at Doses of 100, 300 and 500 mg Administered Once Daily in Patients With Moderate to Severe Psoriasis With a 12 Week Treatment Extension
status: COMPLETED
study design: INTERVENTIONAL
phase: PHASE2
start date: 2006-06
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT00333411
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: Boehringer Ingelheim
study subject: Psoriasis
keywords: PHASE2
keywords: INTERVENTIONAL
keywords: COMPLETED
keywords: Psoriasis

AI Analytics
type: Organization